 |
|
|
| |
Interferon- and Ribavirin-Free Regimen of ABT-450/r and ABT-267 in Treatment-Experienced Japanese Patients Infected With HCV Genotype 1b or Genotype 2
|
| |
| |
Reported by Jules Levin
Presented at the Asian Pacific Association on for the Study of the Liver, 12-15 March 2014, Brisbane, Australia
K Chayama1, K Notsumata2, M Kurosaki3, K Sato4, L Rodrigues Jr5, C Setze5, P Badri5, T Pilot-Maias5, RA Vilchez5, H Kumada6
1Hiroshima University, Higashi-Hiroshima, Japan; 2Fukuiken Saiseikai Hospital, Fukui, Japan; 3Musashino Red Cross Hospital, Musashino, Japan; 4Gunma University Hospital, Maebashi, Japan;
5AbbVie Inc., North Chicago, Illinois, United States; 6Toranomon Hospital, Tokyo, Japan
|
| |
|
|
|
|
|
